Page last updated: 2024-09-03

wr 99210 and Koch's Disease

wr 99210 has been researched along with Koch's Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kumar, M; Subba Rao, G; Vijayakrishnan, R	1

Other Studies

1 other study(ies) available for wr 99210 and Koch's Disease

Article	Year
In silico structure-based design of a novel class of potent and selective small peptide inhibitor of Mycobacterium tuberculosis Dihydrofolate reductase, a potential target for anti-TB drug discovery. Molecular diversity, 2010, Volume: 14, Issue:3 Topics: Amino Acid Sequence; Antitubercular Agents; Binding Sites; Computational Biology; Crystallography, X-Ray; Drug Design; Folic Acid Antagonists; Humans; Hydrogen Bonding; Ligands; Methotrexate; Microbial Sensitivity Tests; Molecular Dynamics Simulation; Molecular Sequence Data; Mycobacterium tuberculosis; Ornithine; Peptides; Pterins; Reproducibility of Results; Substrate Specificity; Tetrahydrofolate Dehydrogenase; Triazines; Tuberculosis	2010

Article

Year

In silico structure-based design of a novel class of potent and selective small peptide inhibitor of Mycobacterium tuberculosis Dihydrofolate reductase, a potential target for anti-TB drug discovery.

Molecular diversity, 2010, Volume: 14, Issue:3

Topics: Amino Acid Sequence; Antitubercular Agents; Binding Sites; Computational Biology; Crystallography, X-Ray; Drug Design; Folic Acid Antagonists; Humans; Hydrogen Bonding; Ligands; Methotrexate; Microbial Sensitivity Tests; Molecular Dynamics Simulation; Molecular Sequence Data; Mycobacterium tuberculosis; Ornithine; Peptides; Pterins; Reproducibility of Results; Substrate Specificity; Tetrahydrofolate Dehydrogenase; Triazines; Tuberculosis

2010